CLSI NBS05
Newborn Screening for Cystic Fibrosis, 2nd Edition
This guideline describes newborn screening laboratory tests for detecting analytes and genetic markers associated with cystic fibrosis (CF). It includes both the first-tier and second-tier screening tests performed on newborn dried blood spot specimens, as well as the screening strategies for identifying newborns at increased risk for developing CF.
Member price:
List Price:Details
Chairholder: Debra Freedenberg, MD, PhD, FFACMG
Date of Publication: December 19, 2019
Order Code PDF: CLSI NBS05Ed2E
ISBN Number: 978-1-68440-065-2
Order Code Print: CLSI NBS05Ed2
ISBN Number: 978-1-68440-064-5
Edition: Second
Pages: 86
CLSI NBS05 Additional Details
A guideline for global application developed through the Clinical and Laboratory Standards Institute consensus process.
This document was formerly sold under the code ILA35.